These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20141724)

  • 41. Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring.
    Mainie I; Tutuian R; Agrawal A; Hila A; Highland KB; Adams DB; Castell DO
    Thorax; 2005 Jun; 60(6):521-3. PubMed ID: 15923255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
    Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
    J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
    Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New insights into the assessment of gastro-oesophageal reflux disease.
    Collard JM
    Acta Chir Belg; 1996; 96(4):144-9. PubMed ID: 8830868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent heartburn in a patient on proton-pump inhibitor.
    Fass R
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):393-400. PubMed ID: 18387497
    [No Abstract]   [Full Text] [Related]  

  • 48. Head and neck manifestations of gastroesophageal reflux disease.
    Ahuja V; Yencha MW; Lassen LF
    Am Fam Physician; 1999 Sep; 60(3):873-80, 885-6. PubMed ID: 10498113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fundoplication for laryngopharyngeal reflux disease.
    Westcott CJ; Hopkins MB; Bach K; Postma GN; Belafsky PC; Koufman JA
    J Am Coll Surg; 2004 Jul; 199(1):23-30. PubMed ID: 15217625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
    Kashin SV; Ivanikov IO
    Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hoarseness in adults.
    Feierabend RH; Shahram MN
    Am Fam Physician; 2009 Aug; 80(4):363-70. PubMed ID: 19678604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonacid reflux episodes reaching the pharynx are important factors associated with cough.
    Patterson N; Mainie I; Rafferty G; McGarvey L; Heaney L; Tutuian R; Castell D; Johnston BT
    J Clin Gastroenterol; 2009; 43(5):414-9. PubMed ID: 19197196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin.
    Gill GA; Johnston N; Buda A; Pignatelli M; Pearson J; Dettmar PW; Koufman J
    Ann Otol Rhinol Laryngol; 2005 Dec; 114(12):913-21. PubMed ID: 16425556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [pH-impedancemetry: clinical implications].
    Bertolini D; Roman S; Dumonceau JM
    Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual-probe pH monitoring for the assessment of gastroesophageal reflux in the course of chronic hoarseness in children.
    Kalach N; Gumpert L; Contencin P; Dupont C
    Turk J Pediatr; 2000; 42(3):186-91. PubMed ID: 11105615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic lesions.
    Galli J; Calò L; Agostino S; Cadoni G; Sergi B; Cianci R; Cammarota G
    Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):377-82. PubMed ID: 15108488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pepsin immunoassay in the sputum for detection of laryngopharyngeal reflux].
    Li XP; Chen SJ; Wang L; Liu X; Liu YL; Zeng FF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Feb; 44(2):99-104. PubMed ID: 19558879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Examination of the aero-digestive tract during routine endoscopy.
    Chong VH
    Dig Liver Dis; 2010 Jan; 42(1):74. PubMed ID: 19482566
    [No Abstract]   [Full Text] [Related]  

  • 60. US perspective on off-label use in pediatrics.
    Karesh A; Mulberg AE
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):113-4. PubMed ID: 23254442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.